The European Multiple Sclerosis Platform presents our 2024 Annual Report, documenting a year of significant achievements in our mission to improve the quality of life for people affected by Multiple Sclerosis (MS), Neuromyelitis Optica Spectrum Disorders (NMOSD) and Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease (MOGAD) throughout Europe.
Over the past two years, EMSP brokered paid internships with multinational companies for ten young people living with multiple sclerosis (MS) in Europe,...
Please note:
This action will also remove this member from your connections and send a report to the site admin.
Please allow a few minutes for this process to complete.